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Abstract
Background: The algorithmic approach to guidelines has been introduced and promoted on a large scale since
the 1970s. This study aims at comparing the performance of three algorithms for the management of chronic
cough in patients with HIV infection, and at reassessing the current position of algorithmic guidelines in clinical
decision making through an analysis of accuracy, harm and complexity.
Methods: Data were collected at the University Hospital of Kigali (CHUK) in a total of 201 HIV-positive hospitalised
patients with chronic cough. We simulated management of each patient following the three algorithms. The first
was locally tailored by clinicians from CHUK, the second and third were drawn from publications by Médecins sans
Frontières (MSF) and the World Health Organisation (WHO). Semantic analysis techniques known as Clinical
Algorithm Nosology were used to compare them in terms of complexity and similarity. For each of them, we
assessed the sensitivity, delay to diagnosis and hypothetical harm of false positives and false negatives.
Results: The principal diagnoses were tuberculosis (21%) and pneumocystosis (19%). Sensitivity, representing the
proportion of correct diagnoses made by each algorithm, was 95.7%, 88% and 70% for CHUK, MSF and WHO,
respectively. Mean time to appropriate management was 1.86 days for CHUK and 3.46 for the MSF algorithm. The
CHUK algorithm was the most complex, followed by MSF and WHO. Total harm was by far the highest for the
WHO algorithm, followed by MSF and CHUK.
Conclusions: This study confirms our hypothesis that sensitivity and patient safety (i.e. less expected harm) are
proportional to the complexity of algorithms, though increased complexity may make them difficult to use in
practice.
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The algorithmic approach to guidelines has been intro-
duced and promoted on a large scale since the 1970s.
This flowchart representation of step-by-step clinical
logic guides the management of a patient with symp-
toms, clinical signs, or results of technical examinations.
The transition from one step to the next is mostly
dichotomous, which means that only one out of two
choices can be made at each step. Moreover, the logic is
s e r i a l :o n l yo n ep a t h w a yc a nb ef o l l o w e db yas i n g l e
patient.
The original purpose of algorithmic guideline imple-
mentation was twofold. First, with continuing concern
over the rising costs of health care, health policy makers
have been impressed by the high levels of variation and
inappropriateness in medical care. Second, in resource-
poor settings, nurses provide frequently the first-line
medical care. To deal with the relative lack of knowl-
edge in this medical professional group, algorithms have
been used to help rationalise and standardise clinical
decision making, an approach considered so far to be
effective and efficient [1]. Algorithms have been pivotal
in the task-shifting or task-sharing by nurses that has
been promoted over the last 10 years to increase access
to antiretroviral therapy.
Clinical algorithms are often controversial: on the one
hand, they have often been considered with suspicion
because of their restrictive, “cookbook"-medicine
approach. On the other hand, they have been viewed as
a valuable educational tool, providing neophytes with a
method for making diagnostic and therapeutic decisions
in clinical practice apprenticeship [2]. Although both of
t h e s ev i e w sm a ym a k es e n s e ,n o n eo ft h e mh a sb e e n
validated.
Algorithms usually lead to a single diagnosis, poten-
tially neglecting another serious one, leading to delayed
investigations and treatment. In some situations, the
burden of harm might grow considerably: when we fol-
low an algorithmic guideline step-by-step, it is obvious
to stop at the first diagnosis corresponding with the
patient’s findings. It induces a tunnel-vision and limits
the search of certainty in diagnosis.
Epidemiology shows the relevance of the dynamics of
the disease spectrum in time as well as in space. The
utility of a given clinical algorithm can vary substantially
across different epidemiologic and socioeconomic con-
texts. As a result, every algorithmic guideline must be
adapted to every local context and regularly revised [3].
Moreover, the emphasis on development and deploy-
ment of medical guidelines has led to the introduction
of multiple versions addressing the same problem:
uncertainty is increased with the fact that clinicians
have to select among several guidelines. Barak et al.
tried to solve this problem by creating a method of text-
to-algorithm conversion [2].
Several studies have evaluated or compared guidelines
but none of them has compared them in terms of com-
plexity or harm [4-7]. Wabitsch, in his efforts to achieve
reproducible, clinically flexible and applicable guidelines,
developed a systematic procedure to tailor guidelines to
specific settings. Doing this, he compared two modified
guidelines with a global one, but he did not consider
harm [3]. Because of the impact guidelines may have on
clinical practice, Pearson et al. proposed a method to
develop, use and compare them [8]. This methodology-
the Clinical Algorithm Nosology (CAN)-measures over-
all design complexity independent of algorithm content,
quantitatively delineates algorithm differences, and qua-
litatively estimates the potential impact of such differ-
ences on patient care, by scoring the degree of
similarity. This simple method may help clinicians to
make the best choice between several algorithms about
the same subject or complaint in their setting.
At the end of 2007 the global estimate of the number
of people living with HIV was about 33,2 million, with
more than 96% in low- and middle-income countries
[9]. In Rwanda, HIV prevalence turns around 2,9 to
3,2% [10].Except for some countries, the majority of
people living with HIV still have no access to highly
active antiretroviral therapy (HAART). Chronic cough is
a key problem of medical decision making in the man-
agement of immune-compromised HIV patients, since a
large cluster of dangerous but treatable diseases present
this way.
The purpose of this research was to compare virtually
three algorithmic guidelines intended for use at a ter-
tiary level in terms of sensitivity, delay to diagnosis,
harm, complexity and similarity. We intended to evalu-
ate how complexity relates to accuracy and expected
harm. We hypothesized that increasing complexity,
thereby approaching the clinician’si n t u i t i v el o g i c ,
improves accuracy and diminishes expected harm, but
that, on the other hand, the degree of complexity can
become too high and make the algorithm less useful in
practice.
Methods
Patients
Data were collected at the University Hospital of Kigali
(CHUK), a national reference centre for Rwanda, during
a 4 months period in 2002. The study included all adults
(> 15 years of age) hospitalised in the internal medicine
department with cough of more than three weeks’ dura-
tion as their chief complaint, known or newly confirmed
HIV-positive and suspected of World Health Organisa-
tion (WHO) stage 3 or 4 [11]. Patients who had a
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Page 2 of 10known non-infectious cause of chronic cough (chronic
obstructive lung disease, bronchial asthma, pleural effu-
sion due to cardiac or renal insufficiency) were excluded
from the study. The reference standard for the actual
disease of each patient was the final diagnosis made by
clinicians at the end of the follow-up with the available
diagnostic tools (e.g., chest X-ray, Gram and Ziehl-Neel-
s e ns t a i n ,c u l t u r e ;b r o n c h o s c o p yw a sd o n ef o rs e l e c t e d
cases).
Clinical care depended only on the clinician’sj u d g -
ment. Moreover, clinicians were blinded to hypothetical
results of the application of the algorithms.
For each patient, we collected data through a ques-
tionnaire in Epi-Info software 2000: age, sex, history,
physical examination, tests done, treatment, outcome
and final diagnosis. Data were made anonymous for ana-
lysis. Sensitivity was computed with and without consid-
ering patients for whom no final diagnosis was made
and those with a rare diagnosis not included in the algo-
rithms. For the remainder of the analysis they were
excluded.
Algorithms
Using the graphic format described by Margolis, a serial
and dichotomous flowchart representation adopted by
the Harvard Community Health Plan, a locally tailored
algorithm was developed based on clinicians’ logic and
availability of complementary exams (Figure 1). Two
residents, under the supervision of their professor of
internal medicine, created the CHUK algorithm. They
were not amongst the clinicians who made the final
diagnosis considered as the gold standard. Clinicians
only controlled the construction of the algorithm for
inconsistencies.
The Médecins sans Frontières (MSF) algorithm was
published in 2001 by L. Lynen for management of
opportunistic infections in HIV-positive patients, and
based on an extensive literature review (Figure 2)
[12,13]. The WHO algorithm was published earlier in
the 1990s (Figure 3) [14]. Both publications proposed
guidelines for care at three levels. In our assessment of
the three algorithms we only used the chronic cough
algorithm for the tertiary care level.
Evaluation
We virtually applied the three algorithms to each
patient, using data from the database, simulating a step-
by-step management as would have been done following
the algorithm. We calculated the number of patients
who found a way through the algorithm ("fit”)a n dw e
compared their management in the ward with the path-
way they would have followed with the algorithm. Sensi-
tivity represents the proportion of correct diagnosis
made by an algorithm. We estimated the sensitivity first
for each diagnosis, and further for the algorithm as a
whole, with the final clinical diagnosis as the “true con-
dition”. If the algorithm missed a diagnosis, we consid-
ered this as a false negative for the true condition. If
1
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Figure 1 THE CHUK ALGORITHMIC GUIDELINE.
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Page 3 of 10another diagnosis was reached instead of the true condi-
tion, it was considered as a false negative for the true
condition and as a false positive for the wrong condi-
tion. In other words, the false positive is a wrong diag-
nosis whereas the false negative is a missed diagnosis.
Starting from the clinical state box to the action box,
we defined for each diagnosis a minimal hypothetical
(ideal) delay, depending on the execution of the different
investigations. For every patient we compared the time
clinicians needed in the ward to reach a therapy, with
the delay predicted by the different algorithms. Delays
were considered on theoretical grounds, supposing that
all steps had to be taken in a sequential way (which clin-
icians often don’t do: e.g., if the X-ray shows a miliary
pattern, they will not wait for all three sputa
examinations).
We compared the algorithms following the Clinical
Algorithm Nosology. It is made up of two components
[8]. The Clinical Algorithm Structural Analysis (CASA)
measures overall design and flow pattern complexity
independent of algorithm content. A formula expresses
the relative complexity of a clinical algorithm in a score:
CASAcomplexity score =2 ( n 1Dx)+1 ( n 2D0)+

(Lp)i
where n1Dx = number of diagnostic boxes, n2D0 =
number of all other boxes, and ∑ (Lp) i = the summation
of “loop parameters” (i.e. nodes that send the clinician
back to an earlier point). The Clinical Algorithm Patient
Abstraction (CAPA) then accomplishes a clinical com-
parison of two algorithms and explains the differences
between them. The CAPA has three steps: clinical rule
analysis, patient abstraction and patient comparison.
“Identical” (score = 10) means same order of clinical
exams and decision, “similar” (score = 8) means the
same steps and treatment but in different order and
“different” (score = 0) means a management without the
same diagnosis or therapeutic decision.
With a questionnaire featuring scoring scales from 0
to 10, nine internal medicine clinicians of CHUK esti-
mated intuitively the weight of harm by commission
(false positives) and harm by omission (false negatives)
in therapeutic decisions compared to natural death [15].
We relied only on intuitive estimations, after a training
session explaining the different key factors determining
harm: disease and treatment morbidity and mortality,
treatment efficacy and cost, stigma, contagiousness. For
each algorithm we computed the harm per diagnosis,
multiplying false positives and false negatives with their
respective harm, and summing these for the overall
harm.
Results
Data were recorded for 201 patients. Nine patients had
no diagnosis, 9 had a rare diagnosis not included in the
algorithms, leaving 183 for analysis. One patient had
two probable diagnoses. Sex ratio was 82/119 M/F
(0,69), mean age was 35,9 years (range 15-70 years).
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Figure 2 THE MSF ALGORITHMIC GUIDELINE.
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Page 4 of 10Baseline characteristics and main diagnostic frequencies
are summarized in table 1. (Table 1) All forms of tuber-
culosis were by far the most frequent diagnosis (46,4%).
Mortality was high (39%).
Of the 184 cases (one patient with 2 diagnoses) we
made follow the CHUK algorithm, 183 fit a pathway
(99,5%). Comparing the algorithm pathways with the
one followed by the clinicians, for 61% the management
was “identical”,f o r3 8 %i tw a s“different” and for 1% it
was “similar”.
The same procedure was also applied for each of the
184 cases to the other two algorithms under study. A fit
was found in 183 (99.5%), 183 (99.5%), and 171 (92.9%)
cases for the CHUK, MSF and WHO algorithms,
respectively. Sensitivity was 95.7%, 88% and 70.1% for
the CHUK, MSF and WHO algorithms, respectively
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Figure 3 THE WHO ALGORITHMIC GUIDELINE.
Mukabatsinda et al. BMC Medical Informatics and Decision Making 2012, 12:2
http://www.biomedcentral.com/1472-6947/12/2
Page 5 of 10(87.5%, 80.5% and 64.2 while including patients with
unknown and rare diagnosis). (Table 2)
Table 3 shows that for most diagnoses a certain delay
to appropriate management was present. (Table 3) For
example, for empyema, seven days were lost by the
CHUK clinicians before a therapeutic action. When we
compare the average delay of CHUK and MSF guide-
lines with the hypothetical minimal delay according to
the local situation regarding availability and speed of
execution of tests and treatments, the CHUK algorithm
was the fastest, followed by that of MSF. For the WHO
algorithm, delays were difficult to calculate because of
missing practical specifications.
The CHUK algorithm was the most complex with a
CASA score of 80, followed by MSF with a score of 73
and WHO with a score of 40. The CAPA score was 0
meaning that there is (almost) no similarity between the
three algorithms.
Table 4 shows the average intuitive harm for false
positives and negatives for each disease, weighted by the
nine internal medicine clinicians compared to natural
death. On average, the weight of omission error was
much higher than the weight of commission error (8
versus 4.5). The total harm was the highest for the
WHO algorithm with a score of 487.5. On the other
hand, the CHUK algorithm was by far the least harmful
followed by MSF algorithm with scores of 91 and 240,
respectively. If we split total harm into “false-positive
harm” and “false-negative harm”, we obtain, respectively,
for CHUK scores of 27 and 63, for MSF 64 and 176 and
for WHO 60 and 427.
Discussion
Results
The purpose of this study was to assess the hypothetical
utility of three algorithms in terms of sensitivity, delay
to action and harm at a tertiary care level. The CHUK
guidelines proved to be the most complex, but the most
Table 1 baseline characteristics of patients (n = 201).
Age (years) Count %
15-24 22 11
25-34 72 36
35-44 69 34,5
45-54 29 14
55-64 8 4
65-74 1 0,5
sex
male 82 41
female 119 59
Diagnosis
TB smear positive 43 21,4
Pneumocystis jirovecii 39 19,4
Pleural TB 25 12,4
Lobar pneumonia 21 10,4
Miliar TB 18 9
Atypical pneumonia 18 9
Kaposi ‘s sarcoma 7 3,5
Empyema 3 1,5
Pulmonar abscess 3 1,5
Mediastinal adenopathy (ADP) TB 3 1,5
Cavitary TB 2 1
Pericardial TB 2 1
Other diagnosis* 9 4,5
no diagnosis 9 4,5
Other diagnosis: encephalitis, other forms of extra pulmonary TB x 4, (newly
diagnosed) heart failure, haemolytic anaemia, pneumothorax, cryptococcal
meningitis.
Table 2 details of accuracy of three algorithms.
Diagnosis N° algo CHK algo MSF algo OMS
false
pos
true
pos
false
neg
true
neg
fit false
pos
true
pos
false
neg
true
neg
fit false
pos
true
pos
false
neg
true
neg
fit
TB BK+ 43 1 42 1 140 43 0 43 0 141 43 0 43 0 141 43
miliary TB 18 0 18 0 166 18 0 18 0 166 18 0 18 0 166 18
pleural TB 25 0 24 1 159 25 0 25 0 159 25 0 3 22 159 24
PCP 39 0 39 0 145 39 0 39 0 145 39 0 39 0 145 39
lobar pneumonia 21 3 20 1 160 21 0 1 20 163 21 0 1 20 163 21
atypical
pneumonia
18 1 17 1 165 18 20 18 0 146 18 20 18 0 146 18
empyema 3 0 3 0 181 3 0 3 0 181 3 0 0 3 181 0
Kaposi 7 0 7 0 177 7 0 7 0 177 7 0 7 0 177 7
pulmonal abcess 3 0 0 3 181 2 1 3 0 180 3 0 0 3 181 0
cavitary TB 2 1 2 0 181 2 0 0 2 182 1 0 0 2 182 0
TB ADP
mediastinal
3 1 2 1 180 3 0 3 0 181 3 0 0 3 181 0
TB pericarditis 2 0 2 0 182 2 0 2 0 182 2 0 0 2 182 1
globally 184 7 176 8 2017 183 21 162 22 2003 183 20 129 55 2004 171
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increasing complexity improves sensitivity and
diminishes expected harm. But the degree of complexity
becomes so high that it might be one of the reasons
why clinicians are reluctant to use them. As a matter of
fact, none of these algorithms has ever been used in
daily practice in CHUK.
Epidemiology
Due to limited diagnostic means, the gold standard in
this study is the clinical diagnosis made by the clinicians
at CHUK. This might be considered as a weakness.
However, the prevalence of fi n a ld i a g n o s e si sc l o s et o
the spectrum of diseases that cause chronic cough in
people living with HIV in Africa [10]: tuberculosis
remains the main diagnosis, found in 46% of cases in
our study. It is now well described that tuberculosis is
the leading opportunistic infection in most low-resource
settings, unlike industrialised countries in which a pre-
ponderance of Pneumocystis jirovecii (formerly carinii)i s
seen. Our study reveals a prevalence of 19% of pneumo-
cystosis. This is fourfold the prevalence found by
Batungwanayo in the same hospital ten years earlier, but
this result was based on microbiological evidence after
bronchoscopy and was restricted to unsolved cases [16].
In Uganda bronchoscopy in smear negative patients
showed pneumocystosis in 38% [17]. Since in our study
the diagnosis of pneumocystosis was made mainly radi-
ologically, and since we consider all patients with persis-
tent cough, these data are difficult to compare. A review
in Thailand of causes of all respiratory symptoms in
HIV infected patients found 23% cases of pneumocysto-
sis, a rate more similar to our data [18].
In our study, mortality rate was high (39%). At that
moment in time, ART was not subsidized; patients
feared hospitalisation in our wards because they knew
beforehand the high mortality, leading to late referral or
consultation. Beyond this, some deaths could be attribu-
ted to missed diagnosis of uncommon diseases.
Delay
The average delay to appropriate management would be
shorter for the CHUK algorithm (1.8 days) than for the
MSF (3.4 days). The CHUK delay is therefore closer to
that seen in clinical practice at CHUK, as well as to the
ideal one (Table 3). The theoretical differences between
CHUK and MSF algorithms can be explained by the
sequence of investigations:C H U Ka l g o r i t h mf o c u s e d
first on an X-ray to diagnose urgent pathologies, while
MSF first focuses on sputum smears to diagnose the
most frequent pathology (TB). In practice the X-ray
results are read on day 1 while the sputa are being
analyzed.
The delay of the WHO algorithm was difficult to evalu-
ate because this guideline is mostly theoretical and gives
Table 3 theoretical delay in days if tests were performed in a serial way.
Final Clinical Diagnosis CHUK MSF Actual delay in CHUK Hypothetical minimal delay
TB smear positive 3,14 2,91 2,3 3
Miliary TB 1 3 1,6 1
Pleural TB 2,28 4 3,4 2
Pneumocystis jirovecii 1,03 3,45 0 1
Lobar pneumonia 1,09 3,09 0,8 1
Atypical pneumonia 1,67 4,83 0,2 1
Empyema 1,67 3,67 6,7 2
Kaposi ‘s sarcoma 1,57 3,14 1,6 1
Pulmonary abscess 1 3 1 1
Cavitary TB 1,5 3 0 1
Mediastinal ADP TB 4,33 6 3 1
Pericardial TB 2 4 0 1
Average delay 1,86 3,46 1,8 1,3
Table 4 estimation of intuitive harm.
Diagnosis False Negatives False Positives
TB smear positive 9 5
Miliar TB 8,5 5
Pleural TB 7,5 4,5
Pneumocystis jirovecii 8 3
Lobar pneumonia 8 3
Atypical pneumonia 7 3
Empyema 8 4
Kaposi ‘s sarcoma 7 7,5
Pulmonar abscess 8 4
Cavitary TB 8 5
Mediastinal ADP TB 7,5 5
Pericardial TB 8 5
Average 8 4,5
Average of estimation of intuitive harm of false negatives and false positives
for each diagnosis. Nine internists scored on a scale from 0 to 10.
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into practice is more complex and becomes impossible
for several diagnoses, leaving a lot of freedom to the clin-
ician. To illustrate this, there is no way to distinguish
lobar and atypical pneumonia; in pleurisy, they recom-
mend doing a tap, but there is no explanation about the
interpretation of the results or about steps to take.
Sensitivity, harm and complexity
The analysis of the algorithms brings to the fore that the
CHUK algorithm is the one that leads to the highest sen-
sitivity and induces the lowest harm in terms of morbid-
ity and mortality. This is probably because we tried to
come as close as possible to the intuitive reasoning of the
experienced CHUK clinicians. The algorithm was devel-
oped by trainees of the CHUK clinicians, and CHUK
clinicians are used in this analysis as the gold standard.
On the other hand, it is by far the most complex with a
h i g hC A S As c o r eo f8 0 .P a r to ft h eh i g hc o m p l e x i t yi n
the CHUK algorithm is explained by the presence of
many loops. We see a clear inverse relation between the
increasing sensitivity and the decreasing harm for all
three algorithms. In addition, with regards to the sensitiv-
ity we note that despite such a complexity, 8 patients
(4,3%) would not reach a correct final diagnosis.
Weaknesses
Epidemiology
Firstly we noticed that in the set of patients and also in
the different diagnoses available in the CHUK algorithm,
uncommon but treatable diseases such as aspergillosis,
nocardiosis, cryptococcosis, and some others are not
taken into account. These diseases, however, are well
described as opportunistic infections in HIV-positive
patients and deserve priority before considering frequent
diseases because of their seriousness and treatability.
We omitted them from the analysis since algorithms
cannot cover all rare diseases.
Secondly, in current practice in low resource settings,
diagnosis of pulmonary infection is often a presumption,
based on clinical signs and radiological results because
of the limited availability of serology, culture or PCR.
These presumptive diagnoses were considered as gold
standard-not always with formal proof. It casts doubt on
the reliability of the comparison of the diagnosis
obtained by following the algorithm with the gold stan-
dard diagnosis, as the latter may have been false. The
ideal situation should offer availability of complementary
exams to confirm these presumptive diagnoses, but it
would imply submitting patients to invasive procedures
and spending much more money. Moreover, in
advanced AIDS, more than one pathogen is frequently
identified [18,19].
Finally, a large part of the difference in sensitivity of
the CHUK and MSF algorithms is due to one single
step differentiating between lobar and atypical
pneumonia.
Algorithms and CAN
The three algorithms might not be comparable: the
WHO algorithm leaves much to the discretion of the
clinician, without specifications.
The CAN methodology can be applied easily. By itself,
however, it does not judge which of the algorithms is
likely to provide better patient care. This sole method of
comparison is not really used in practice and remains
an elusive concept. It is only a comparative tool to
quantify the degree of similarity and complexity with no
attention for sensitivity and harm which is the most
important quality of a diagnostic aid. The authors men-
tion that the ideal objective in the comparison of algo-
rithms would involve decision analyses of the
management pathways and prospective clinical trials
comparing patient outcome in guided care [8]. Decision
analysis would include sensitivity analysis of sensitivity
and specificity of every finding for every concerned dis-
ease, of different sequences of nodes, and expressing
global harm in DALY’so rQ U A L I ’s for every disease.
An almost impossible task, at least for complex algo-
rithms as the ones discussed here. On the other hand,
prospective clinical trials would involve huge sample
sizes, as for every disease a sufficient number of patients
should be included. Moreover, ethical requirements
should be met.
So far, a practical way of comparing clinical guidelines
proving their reliability before their implementation is
still needed to validate any guideline program [8]. In our
study, we did not apply algorithms in real patients and
evaluate the outcome. We consider that our methodol-
ogy is anyhow a necessary first step in validation: a cor-
rect scientific output is reached without the risk of
increasing harm applying algorithms in real clinical deci-
sion making.
Estimation of harm
Intuitive weighting of harm is a gross intuitive estima-
tion given by clinicians on a simple scale scoring from 0
to 10 about commission error (false positives) and omis-
sion error (false negatives) in therapeutic decisions. Cal-
culated weighed harm is more accurate than intuitive
weighed harm, because it is based on observed probabil-
ities related with the outcome of treated and non treated
diseased and non diseased patients. In a recent study, we
proved that the ratio of the intuitively estimated harm
was almost 32 times lower than the calculated based on
(by the same clinicians) intuitively estimated influencing
factors, and two times lower than the calculated
weighed harm based on literature data [20]. For our
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http://www.biomedcentral.com/1472-6947/12/2
Page 8 of 10study and purpose, we relied only on the intuitive one
to draw conclusions, conscious of the lack of accuracy.
Impact
Our study has shown that some published algorithms
have limited accuracy. This can be overcome by increas-
ing the complexity, at the possible expense of user-
friendliness. We hope that this study encourages policy-
makers to “dry-run” new draft-algorithms with an exist-
ing database of a cohort of patients, before organizing a
formal validation in a real situation. The latter is not
always possible, given the lack of a gold standard in
most situations where the algorithm is to be applied.
A second impact of this study might be that writing
algorithms for problems with a large differential diagno-
sis at the tertiary care level should be abandoned for
many reasons, for instance: the burden of work neces-
sary to adapt the algorithm to time and place, the
neglect of rare but serious and treatable diseases, the
possible coexistence of several pathologies, the reduction
of a clinical presentation to only a few signs, and the
difficulty in reaching a reasonable accuracy. We might
state that at this level of care, medical decision tools
based on a serial dichotomous approach may be
replaced by the more human parallel and weighed logi-
cal approach recently proposed [20-23].
Future research
Little research has been done to evaluate the real-world
use of algorithms by health professionals [1,3]. Anecdo-
tal evidence shows that most nurse practitioners do not
follow their algorithms. As far as we are concerned, doc-
tors never follow them for diagnosis; simple therapeutic
flow-charts on the other hand, do well.
The concept of threshold approach in clinical deci-
sion-making has existed since the 1970s, and this con-
cept has been substantiated to the point that ignoring it
would be unethical [24-26]. All the more, a threshold
approach might solve many conflicts provoked by the
algorithmic logic: future studies will have to demon-
strate it.
Considering that application of an algorithmic
approach involves a short course training, especially for
nurses and inexperienced personnel, future studies
should assess which logical approach is the most effec-
tive for a given amount of training [23].
Conclusion
Inexperienced medical staff could go on using the algo-
rithmic approach in order to solve simple problems at
the first level of care. The condition is that they should
have a short basic training and that the flowchart should
be validated, adapted to the local context and regularly
revised. But at the tertiary care level, approaching the
competence of specialised clinicians by improving sensi-
tivity and diminishing expected harm will increase com-
plexity at that point that it turns out almost impossible
to apply.
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